A pharmaceutical composition for the treatment of an increased urge to urinate
or urinary incontinence, comprising an effective amount of at least a compound
selected from the group consisting of codeine, dihydrocodeine, dextropropoxyphene,
meptazinol and tilidine. Also disclosed are methods of treatment using the pharmaceutical
compositions and preferred dosages for the treatment methods.